Missing/wrong data? Edit Wikidata item
Lenvatinib is independently associated with the reduced risk of progressive disease when compared to sorafenib in patients with advanced hepatocellular carcinoma
scientific article published on 20 November 2020
Author/s
Work details
Publication date:
November 20, 2020
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.